Literature DB >> 3089660

Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease.

C E Frasch, C M Tsai, L F Mocca.   

Abstract

Meningococcal meningitis is a serious disease with a high incidence in children. Since meningococcal surface structures play a role in invasion of the host and initiation of disease, host defense mechanisms are directed against these meningococcal structures. All virulent meningococci are encapsulated, but other factors are also involved. Only certain serotypes of group B and group C meningococci are strongly associated with disease. Our studies have been directed toward a better understanding of the structure of the meningococcal cell surface. There are five classes of major outer membrane proteins exposed on the cell surface, designated class 1 through 5, based in part upon the protein's molecular weight. Using monoclonal antibodies we have shown that antibodies to the class 1, 2 and 5 proteins of serotype 2 are bactericidal and therefore probably protective. Convalescent sera of meningococcal disease patients have elevated antibody levels to each of these classes of proteins. Outer membrane protein vaccines have been prepared, and clinically evaluated in adults and children as young as 6 mo of age. The vaccines induce serotype specific bactericidal antibodies in all age groups, but they induced lower levels in young children. We are now working to improve the immune response of children through the use of aluminium adjuvants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089660

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  12 in total

1.  Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.

Authors:  J Jelfs; R Munro; E Wedege; D A Caugant
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.

Authors:  M G Danelli; N M Batoreu; M D Lacerda; C R Ferreira; J D Cardoso; J M Peralta; C E Frasch
Journal:  Curr Microbiol       Date:  1995-09       Impact factor: 2.188

3.  Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins.

Authors:  J Tommassen; P Vermeij; M Struyvé; R Benz; J T Poolman
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

4.  Cloning and characterization of the structural gene for the class 2 protein of Neisseria meningitidis.

Authors:  K Murakami; E C Gotschlich; M E Seiff
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

5.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

6.  Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine.

Authors:  E Wedege; T E Michaelsen
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

7.  Sequence of the structural gene (rmpM) for the class 4 outer membrane protein of Neisseria meningitidis, homology of the protein to gonococcal protein III and Escherichia coli OmpA, and construction of meningococcal strains that lack class 4 protein.

Authors:  K P Klugman; E C Gotschlich; M S Blake
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Characterization of Neisseria meningitidis by polymerase chain reaction and restriction endonuclease digestion of the porA gene.

Authors:  D A Kertesz; S K Byrne; A W Chow
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

Review 9.  Adolescent Vaccination Strategies: Interventions to Increase Coverage.

Authors:  Corinne E Lehmann; Rebecca C Brady; Reuben O Battley; Jennifer L Huggins
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.930

10.  Variation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptor.

Authors:  Nicholas J Evans; Odile B Harrison; Kirsten Clow; Jeremy P Derrick; Ian M Feavers; Martin C J Maiden
Journal:  Microbiology (Reading)       Date:  2010-02-11       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.